@article{JTD17258,
author = {Joo Han Song and Ji Eun Park and Jin Gu Lee and Chang Young Lee and Kyung Sik Nam and Jee Won Suh and Anes Kim and Seung Hyun Lee and Hyun Chel Joo and Young Nam Youn and Song Yee Kim and Moo Suk Park and Hyo Chae Paik},
title = {Outcomes of perioperative extracorporeal membrane oxygenation use in patients undergoing lung transplantation},
journal = {Journal of Thoracic Disease},
volume = {9},
number = {12},
year = {2017},
keywords = {},
abstract = {Background: The aim of this single-center study is to review the transplant outcomes of patients receiving lung transplantation (LTx) using intraoperative extracorporeal membrane oxygenation (ECMO) according to the perioperative use of ECMO.
Methods: We retrospectively reviewed the transplant outcomes of 107 consecutive patients who underwent LTx using intraoperative ECMO between March 2013 and August 2016 at Severance Hospital of Yonsei University (Seoul, Korea).
Results: Patients were divided into the following three groups according to the use of perioperative ECMO: only intraoperative ECMO (n=47) or extended post-operative ECMO but no bridging and no postoperative ECMO re-implantation (secondary ECMO; n=28) as Group A (n=75); bridging ECMO without secondary ECMO (n=14) as Group B; and secondary ECMO with (n=7) or without (n=11) bridging as Group C. Baseline demographics were comparable among the three groups. The mean duration of preoperative ECMO bridging was 16.4±15.6 (n=21). After a median of 17.7 months (range, 3.1–40.9 months) for survivors, the one year overall survival (OS) rates after LTx for the three groups were 76.3%±5.2% for Group A, 59.9%±14.3% for Group B, and 14.0%±9.0% for Group C (P},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/17258}
}